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Barbiturates, commonly used as general anaesthetics,
depress neuronal activity and thus cerebral metabolism.
Moreover, they are likely to disrupt the metabolic support
of astrocytes to neurons, as well as the uptake of
nutrients from circulation. By employing 13C magnetic
resonance spectroscopy (MRS) in vivo at high magnetic
field, we characterized neuronal and astrocytic pathways
of energy metabolism in the rat cortex under thiopental
anaesthesia. The neuronal tricarboxylic acid (TCA) cycle
rate was 0.466 0.02mmol/g/min, and the rate of the
glutamate-glutamine cycle was 0.096 0.02mmol/g/min. In
astrocytes, the TCA cycle rate was 0.166 0.02mmol/g/min,
accounting for a quarter of whole brain glucose oxidation,
pyruvate carboxylase rate was 0.0260.01mmol/g/min, and
glutamine synthetase was 0.126 0.01mmol/g/min. Relative
to previous experiments under light a-chloralose anaesthe-
sia, thiopental reduced oxidative metabolism in neurons and
even more so in astrocytes. Interestingly, total oxidative
metabolism in the cortex under thiopental anaesthesia sur-
passed the rate of pyruvate production by glycolysis, indicat-
ing substantial utilisation of substrates other than glucose,
likely plasma lactate. VC 2017Wiley Periodicals, Inc.
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INTRODUCTION
Brain function is supported by sustained supply of
oxygen and nutrients from the blood stream and relies on
synchronized metabolic interaction between neurons and
astrocytes (Hertz et al., 2007; Hyder and Rothman, 2012;
Lanz et al., 2013). Anaesthetics modulate basal neuronal
activity, and modify the coupling between neuronal activ-
ity and vascular regulation of blood flow and volume,
which has been suggested to involve astrocytic signalling
(Masamoto et al., 2012).
Barbiturates are widely used as anaesthetics or anti-
convulsant agents by acting on the GABAA receptor
thereby increasing the opening duration of the Cl- chan-
nel, leading to hyperpolarisation of the plasma membrane
of target cells (Ito et al., 1996). At elevated dose,
barbiturates can be used to profoundly depress cerebral
activity and concomitantly reduce glucose metabolism
(Hodes et al., 1985; Nilsson and Siesjo, 1975; Sokoloff
et al., 1977; Strang and Bachelard, 1973; Crane et al.,
1978). Additionally, barbiturates can directly depress
mitochondrial respiration (e.g., Aldridge and Parker,
1960; Chance and Hollunger, 1963), further contributing
to their role in depressing brain energy metabolism. Ener-
gy metabolism can be studied in the living brain using
13C MRS during administration of 13C-enriched sub-
strates (Henry et al., 2006). By measuring 13C isotope
incorporation over time into specific carbon positions of
different molecules and by analysing these 13C enrich-
ments over time with appropriate mathematical models,
one can determine the rate of oxidative metabolism in
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neurons and astrocytes, as well as the glutamate-glutamine
cycle rate (e.g., Gruetter et al., 2001; Duarte et al., 2011;
Sonnay et al., 2016).
In 13C MRS studies in vivo, pentobarbital was
administered to induce isoelectricity, allowing baseline
metabolic rates to be estimated at a low neurotransmitter
turnover (Choi et al., 2002; Chowdhury et al., 2014).
It has been reported that astrocytic glutamate uptake
is inhibited by the thiobarbiturates thiopental and thiamy-
lal, but not by oxibarbiturates, including pentobarbital,
secobarbital, and amobarbital (Swanson and Seid, 1998).
This suggests that thio- and oxibarbiturates have different
effects on astrocytic metabolism. The aim of the present
study was to investigate neuronal and glial metabolism in
the rat cerebral cortex under thiopental anaesthesia using
13C MRS at high magnetic field upon administration of
[1,6-13C]glucose.
MATERIALS AND METHODS
Animal Preparation for 13C MRS
All experiments involving animals were performed in
accordance with the Swiss federal law on animal experimenta-
tion, approved by the local committee (EXPANIM-SCAV),
and reported following ARRIVE guidelines. [1,6-13C]glucose
(99% 13C enrichment in both C1 and C6) and other reagents
were purchased from Sigma-Aldrich, except where noted.
Male Sprague-Dawley rats (n5 7, 2676 23 g, from Charles
River Laboratoires) were prepared as previously detailed
(Duarte et al., 2009). Rats were briefly intubated under 2% iso-
flurane anaesthesia vaporized in 30% O2 in air and mechanically
ventilated. Catheters were inserted into both femoral veins and
one femoral artery. The venal catheters were used for infusion
of phosphate-buffered saline solutions containing [1,6-13C]glu-
cose, (RS)-(5-ethyl-4,6-dioxo-5-[pentan-2-yl]-1,4,5,6-tetrahy-
dropyrimidin-2-yl)sulfanide sodium (sodium thiopental, Inresa
Arzneimittel), or sodium bicarbonate. The arterial catheter
served to collect blood samples, and monitor heart rate and
arterial blood pressure. The rat’s head was stereotaxically fixed
in a homebuilt MR-compatible holder, and the radiofrequency
coil was placed on top of the head. Body temperature was
maintained at 37 8C with a warm water circulation system based
on the feedback obtained from a homebuilt rectal temperature
probe. Heart rate, blood pressure and breathing rate were con-
tinuously recorded with a SA Instruments monitoring system.
Arterial pH and pressures of CO2 (PaCO2) and O2
(PaO2) were measured with a blood gas analyser (AVL Com-
pact 3, Roche), and were adjusted by regulating both the respi-
ratory rate and volume, and by infusion of NaHCO3 (0.45 M
in saline) to a maximal dose of 3 mmol/kg/h. Plasma glucose
was determined with a Reflotron Plus system (Roche). Lactate
concentrations were measured with a GM7 Micro-Stat analyser
(Analox Instruments).
Once the animal was placed in the scanner, thiopental
(10 g/L in saline) was administered as a 50 mg/kg bolus during
5 minutes while isoflurane anaesthesia was discontinued, and
then maintained at a continuous infusion rate of 90 mg/kg/h.
As previously observed (Duarte and Gruetter, 2012), the high
dose of thiopental led to a decrease in heart rate and arterial
blood pressure. Once heart rate and blood pressure were stable,
about two hours after the thiopental bolus, [1,6-13C]glucose
was infused to reach 70% of fractional enrichment (FE) in plas-
ma within 5 minutes and throughout the entire experiment, as
described previously (Duarte et al., 2011).
MRS Experiments
All experiments were performed on a 14.1 T/26 cm hori-
zontal bore magnet (Magnex Scientific), equipped with 12 cm
gradients (400 mT/m in 120 ls) and interfaced to a direct drive
console (Agilent Technologies) using a homebuilt 1H quadra-
ture surface coil combined with a 13C linearly polarized surface
coil. T2-weighted fast-spin-echo images were used for visualisa-
tion of anatomical landmarks and placement of a volume of
interest (VOI) in the cortex comparable to that of a previous
study (2.238.535 mm3, Sonnay et al., 2016). The static mag-
netic field was homogenized by FAST(EST)MAP shimming
(Gruetter and Tkac, 2000). Amino acid concentrations were
measured by 1H MRS using STEAM with repetition time of 4 s,
echo time of 2.8 ms, and mixing time of 20 ms. 13C MRS was
performed using semi-adiabatic distortionless enhancement by
polarization transfer (DEPT) combined with 3D-ISIS 1H locali-
zation (Henry et al., 2003a). LCModel (Stephen Provencher
Inc.) was used to analyse both 1H and 13C spectra (Henry et al.,
2003b).
After MRS experiment, rats were sacrificed with a
focused microwave fixation device irradiating the brain for 2.2 s
at 4 kW and 2.45 GHz (Gerling Applied Engineering), and the
portion of cortex corresponding to the MRS VOI was dissected.
Samples of cortex and plasma were immediately stored at -80 ˚C
until further processing. Water-soluble metabolites were
extracted with 7% (v/v) perchloric acid. Samples were then
lyophilized, re-dissolved in 2H2O (99.9%
2H, Sigma-Aldrich)
and the p2H was adjusted to 7.0 with 2HCL or NaO2H. Fully
relaxed 1H and 13C MRS in vitro were performed as previously
detailed (Duarte et al., 2007) on a DRX-600 spectrometer
equipped with a 5-mm cryoprobe (Bruker BioSpin SA). FE of
glutamate C3 was estimated from 13C spectra of extracts by cal-
culating C4D34/(C4S1C4D34), where C4D34 and C4S are,
respectively, the doublet and singlet in the resonance of C4 from
glutamate (Duarte and Gruetter, 2013). Note that the total C4
signal corresponds to C4S1C4D34 because glutamate C5 does
not become labelled upon administration of [1,6-13C]glucose
(Duarte et al., 2011). Labelling of glutamate C3 was then used to
calculate labelling in other resonances of the 13C spectra, which
served to scale 13C curves measured in vivo.
Abbreviations
CMRglc cerebral metabolic rate of glucose
DEPT distortionless enhancement by polarization transfer
FE fractional enrichment
MRS magnetic resonance spectroscopy
SD standard deviation
TCA cycle tricarboxylic acid cycle
VOI volume of interest
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Data Analyses
The analyses of data from 13C MRS experiments in the
cortex were performed as described previously (Sonnay et al.,
2016), employing the mathematical model of brain energy
metabolism (supplementary information) previously detailed
(Duarte et al., 2011). Briefly, glucose transport was analysed
with a reversible Michaelis-Menten model using both steady
state and dynamic MRS data (Duarte and Gruetter, 2012).
Steady-state analysis of glucose concentrations measured in cor-
tex and plasma were used to estimate the apparent Michaelis
constant of glucose transport Kt. This value was then con-
strained in the fitting of dynamic 13C curves, determining
therefore the apparent maximum transport rate (Tmax) and the
cerebral metabolic rate of glucose (CMRglc). The two-
compartment model of energy metabolism (Duarte et al., 2011)
was fitted to the group average 13C enrichment curves of all ali-
phatic carbons of glutamate, glutamine and aspartate. Concen-
trations of amino acids were assumed not to vary during
infusion of [1,6-13C]glucose, and were set as total metabolic
pool sizes in the modelling process. The determined parameters
included fluxes through the apparent glutamate-glutamine cycle
(VNT), neuronal and glial TCA cycles (V
n
TCA and V
g
TCA),
exchange between TCA cycle intermediates oxaloacetate and
2-oxoglutarate with the respective amino acids (VnX in neurons
and V
g
X in glia), pyruvate carboxylase (VPC), as well as dilution
fluxes at the level of pyruvate (Vin, Vout), glial acetyl-CoA
(Vdil), and glial glutamine (V
g
ex). Calculated fluxes comprised
the fraction of the glial TCA cycle that results in full oxidation
of pyruvate (Vg5V
g
TCA – VPC), the glutamine synthetase rate
(VGS5VNT1VPC) and the total rate of oxidative glucose
metabolism, that is CMRglc(ox)5 (V
n
TCA1V
g
TCA1VPC)/2.
All data are shown as mean and standard deviation (SD).
For metabolic fluxes, the SD of each parameter was estimated
from fitting a Gamma function to the probability distribution
that resulted from 2000 simulations in a Monte-Carlo analysis
(Duarte et al., 2011; Sonnay et al., 2016). Calculated fluxes
include error propagation in their SD.
A permutation analysis, with 2000 random permutations
followed by individual two-tailed student t-tests, was employed
to compare measured metabolic fluxes to those reported previ-
ously (Sonnay et al., 2016) under identical conditions but with
a-chloralose anaesthesia. P-values were corrected for multiple
comparisons, and significance was considered for P< 0.05.
RESULTS
To achieve stable FE during the 13C MRS experiment,
[1,6-13C]glucose was infused, which resulted in an
increase of plasma glucose concentration (Fig. 1). At the
end of the experiment, FE of glucose C1 was 676 3% in
plasma and 666 3% in brain extracts. Administration of
[1,6-13C]glucose under thiopental anaesthesia increased
plasma lactate concentration (Fig. 1) to 5.76 1.4 mM
during the last hour of [1,6-13C]glucose administration.
FE of lactate C3 reached 496 3% in plasma and 576 7%
in cortex at the end of the experiment. In addition to lac-
tate, plasma alanine and acetate became enriched,
although their respective concentrations were below
1 mM and did not change during glucose infusion. At the
end of the experiment, the FE of alanine C3 and acetate
C2 was 306 26% and 206 4% in plasma, and 526 2%
and 26 3% in cortical extracts, respectively. Note that
blood physiology was maintained within normal limit
under thiopental anaesthesia. Namely, PaCO2 was 42.26
3.4 mm Hg, pH was 7.356 0.05 and O2 saturation was
99.66 0.2%. Average heart rate was 2816 51 bpm, and
systolic and diastolic blood pressures were 1406 11 and
856 19 mm Hg, respectively.
Overall quality of 13C spectra was similar to our pre-
vious study performed in the rat cortex under a-
chloralose (Sonnay et al., 2016), with well-resolved peaks
for glucose C1 and C6, and all the aliphatic carbons of
glutamate, glutamine and aspartate at a temporal resolu-
tion of 10.6 minutes (Fig. 2).
To assess transport kinetics of glucose across the
blood-brain-barrier, brain and plasma glucose concentra-
tions were measured at steady state (Fig. 3A) and evaluat-
ed using reversible Michaelis-Menten modelling, which
resulted in a Kt of 4.56 5.6 mM and a Tmax/CMRglc of
7.86 3.7. To obtain an estimate of Tmax and CMRglc,
dynamic analysis of glucose transport and consumption
was made on glucose enrichment during the first hour of
infusion, since the largest glucose variations occur at the
onset of glucose administration (Fig. 3B). Analysis of
dynamic enrichment of brain glucose upon infusion of
[1,6-13C]glucose with Kt constrained to 4.5 mM resulted
Fig. 1. Plasma concentrations and fractional enrichment (FE) of glu-
cose, lactate, alanine, and acetate. Concentrations of glucose and lac-
tate were measured along the experiment in vivo. FE of metabolites
and concentrations of alanine and acetate were quantified in plasma
extracts by MRS in vitro.
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Fig. 2. Typical 13C spectra acquired at 14.1 T from a volume of 94lL
in the rat cortex during [1,6-13C]glucose infusion under thiopental
anaesthesia. Spectra are shown with a temporal resolution of 10.6
minutes, starting from the [1,6-13C]glucose administration (t5 0). A
time scale for this particular experiment is shown along the spectra.
The top spectrum is the sum of the last 3 spectra. Lorentzian apodiza-
tion (7 Hz) was applied prior to Fourier transformation. Peak assign-
ment: Glc, glucose; Glu, glutamate; Gln, glutamine; Asp, aspartate.
The coronal and sagittal images of the rat brain show the precise VOI
location in the rat cortex.
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in Tmax5 2.66 0.6mmol/g/min and CMRglc5 0.266
0.09mmol/g/min. Although there was a large uncertainty
associated to Kt, this parameter was devoid of major effects
on the estimation of Tmax and CMRglc. Namely, changing
Kt from 0 to 9 mM resulted in Tmax and CMRglc variations
within their SD (Fig. 3C). In turn, CMRglc was devoid of
effect on the fluxes of neuronal and glial metabolism,
excepting the estimation of Vin and Vout.
Concentrations of glutamate, glutamine and aspar-
tate in the rat cortex under thiopental anaesthesia were
10.86 0.9, 4.86 1.4, and 3.56 0.7 mmol/g, respectively,
and used as metabolic pool sizes in the model. To obtain
metabolic rates, the two-compartment model of energy
metabolism (Duarte et al., 2011; Sonnay et al., 2016) was
fitted to the experimentally measured 13C turnover curves
(R25 0.968, Fig. 4A), and uncertainty of estimated param-
eters was assessed by Monte-Carlo analysis (Fig. 5). The rate
of glutamatergic neurotransmission, i.e., the glutamate-
glutamine cycle (VNT), was 0.096 0.02mmol/g/min and
glutamine synthetase (VGS) was 0.126 0.01mmol/g/min.
The fluxes through the tricarboxylic acid cycles in neurons
(VnTCA) and in astrocytes (V
g
TCA) were 0.466 0.02 and
0.166 0.02mmol/g/min, respectively. Pyruvate carboxyla-
tion (VPC) was 0.026 0.01mmol/g/min, representing 15%
of V
g
TCA. In turn, V
g
TCA was about one fourth of total
cortical glucose oxidative metabolism, which is
CMRglc(ox)5 0.326 0.01mmol/g/min. In the present
experiments, estimation of VnX and V
g
X resulted in variances
two orders of magnitude larger than the estimated
value (VnX5 5.796 3.92mmol/g/min; V
g
X5 3.456
2.84mmol/g/min; see Table I). To assess the influence of
experimental noise on the estimated metabolic rates,
Monte-Carlo simulations were performed and the histo-
grams analysed. The uncertainty of the exchange fluxes (VnX
and V
g
X) does not preclude the utilisation of the model for
estimating the remaining fluxes of oxidative metabolism,
which displayed a nearly Gaussian distribution (Fig. 5). The
dilution of acetyl-CoA (Vdil) approached zero in the fitting
and in all Monte-Carlo simulations, as previously observed
in the rat cortex under a-chloralose anaesthesia (Sonnay
et al., 2016). Interestingly, in the present study, CMRglc(ox)
was larger than the glycolytic rate (0.326 0.01 vs. 0.266
0.09mmol/g/min). Therefore, there was no loss of pyruvate
(Vout) but rather a net influx of pyruvate molecules at 0.126
0.09mmol/g/min (Vin-Vout), most probably from lactate.
The results obtained under thiopental anaesthesia in this
study were compared with those acquired in similar experi-
mental conditions but under a-chloralose anaesthesia (Fig.
4B) in a previous study, also in the rat cortex (Sonnay et al.,
2016). When compared to a-chloralose (Table I), thiopental
anaesthesia inhibited CMRglc (-45%), CMRglc(ox) (-29%),
VnTCA (-13%), Vg (-42%), VPC (-67%), and V
g
TCA (-48%).
DISCUSSION
The present study in vivo quantifies for the first time the
relative contribution of neurons and astrocytes under
thiopental anaesthesia, and demonstrates that there is a
depression of neuronal and astrocytic metabolism
(depicted by VnTCA, V
g
TCA and VPC) under such condi-
tions, and an important alteration in the relative fraction
of glucose that is oxidised in each cell type, when com-
pared to identical experiments under light a-chloralose
anaesthesia (Sonnay et al., 2016), as well as to awake rats
(Oz et al., 2004). Namely, while oxidative metabolism
was about 60% in neurons and 40% in astrocytes both in
conscious rats (Oz et al., 2004) and in rats under
a-chloralose anaesthesia (Duarte et al., 2011; Sonnay
Fig. 3. Glucose transport and consumption in the rat cortex. (A)
Description of plasma and cortical glucose concentrations at steady-
state by the reversible Michaelis-Menten model for determination of
Kt. Cortical glucose concentrations at glycaemia below 8 mM were
measured by 1H MRS in vivo before [1,6-13C]glucose infusion. At
plasma glucose above 16 mM, cortical glucose concentrations were
calculated from the FE in cortical extracts and the average [13C]glu-
cose measured in vivo by 13C MRS during the last 30 minutes of
experiment. (B) Dynamic analysis of brain glucose transport and
consumption using brain [13C]glucose (in mmol/g, open symbols) and
plasma [13C]glucose (in mM, filled symbols) during the first hour of
glucose infusion, when cortical glucose changes the most. Plasma
[13C]glucose was estimated from total glucose concentration and the
FE measured in plasma extracts. Cortical [13C]glucose was directly
measured by 13C MRS in vivo. The best fit of the model is repre-
sented by the solid line over the [13C]glucose time course in the cor-
tex. (C) Analysis of the effect of Kt (in mM) on the determination of
Tmax and CMRglc (both in mmol/g/min).
Cortical Energy Metabolism Under Thiopental Anaesthesia 2301
Journal of Neuroscience Research
et al., 2016), astrocytes contributed with only 28% to
whole cortical oxidative metabolism under thiopental.
This is consistent with previous cell culture studies show-
ing larger reduction of glucose uptake in astrocytes (Qu
et al., 1999) than in neurons (Qu et al., 2000).
Barbiturates generally depress cerebral activity and
thus reduce the rate of glucose utilisation (Hodes et al.,
1985; Nilsson and Siesjo, 1975; Sokoloff et al., 1977;
Strang and Bachelard, 1973; Crane et al., 1978), as well as
the rate of oxidative metabolism in both neurons and
astrocytes (Weiss et al., 1972; Hertz et al., 1986; Yu et al.,
1983; Qu et al., 1999, 2000). Namely, employing a meth-
odology similar to that of our study, Oz et al., (2014)
investigated brain energy metabolism in the whole brain
of the awake rat and found VnTCA, V
g
TCA and VPC of
1.136 0.14, 0.546 0.09, and 0.146 0.03mmol/g/min,
respectively. Relative to this study, thiopental anaesthesia
reduced VnTCA by about 60%, V
g
TCA by 70%, and VPC by
80%. Moreover, cell-permeant barbiturates directly
depress mitochondrial respiration (e.g., Aldridge and Par-
ker, 1960; Chance and Hollunger, 1963), and thereby
cause mitochondrial depolarisation and deregulation of
Ca21 homeostasis, resulting in energy depletion that can
eventually facilitate NMDA-induced neurotoxicity
(Anderson et al., 2002). Notably, the brain concentration
of thiopental that was likely achieved in the present study
(Harashima et al., 1997) is in the range that effectively
causes the aforementioned effects in cultured neurons
(30-100 mM, Anderson et al., 2002). However, with this
thiopental dose, we did not find a reduction of
phosphocreatine-to-creatine ratio in the rat brain (Duarte
and Gruetter, 2012) and cortex (Lei et al., 2010), sugges-
ting that the energy status is well preserved in the living
rat brain.
Thiopental was administered at a dose capable of
inducing isoelectricity in the rat brain (Gustafsson et al.,
1996; Harashima et al., 1997). To our surprise, the rate of
the glutamate-glutamine cycle (depicted by VNT) was
similar in experiments performed under thiopental (pre-
sent study) and a-chloralose anaesthesia (Sonnay et al.,
2016), although much smaller than that reported in corti-
cal areas or the whole brain of the awake rat (Oz et al.,
2004; Wang et al., 2010). In contrast, 13C MRS experi-
ments in the whole rat brain found that VNT under pen-
tobarbital anaesthesia (Choi et al., 2002) is less than half of
that under a-chloralose anaesthesia (Duarte et al., 2011).
Fig. 4. Average 13C enrichment curves (in mmol/g) of aliphatic car-
bons of glutamate (Glu), glutamine (Gln) and aspartate (Asp) mea-
sured in the rat cortex, and best fit (solid lines) of the two-
compartment model of brain energy metabolism. Experiments under
thiopental (current study) and a-chloralose (Sonnay et al., 2016)
anaesthesia are shown in panels A and B, respectively. For glutamate
and glutamine, 13C concentration in carbons 4, 3, and 2 are
depicted by circles, squares, and triangles, respectively. For aspartate,
triangles and squares are the 13C concentration in C3 and C2,
respectively.
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This indicates that the tight coupling between energy
metabolism and glutamatergic neurotransmission or
glutamate-glutamine cycle (e.g., Hyder and Rothman,
2012; Lanz et al., 2013) is not maintained under thiopen-
tal anaesthesia. Therefore, one may speculate that the
modulation of neurotransmitter homeostasis by thiopental
might involve different TCA cycle-mediating effects,
such as production of amino acids (Qu et al., 2000). Since
the energy requirements directly linked to the glutamate-
glutamine cycle (e.g. Na1/K1 ATPase extrusion of Na1
that is co-transported with glutamate, glutamine synthe-
tase activity, glutamate transport into vesicles) are relative-
ly small compared to the total energy produced (at the
ATP rates estimated in the present study), the relatively
high metabolic rates measured under thiopental anaesthe-
sia (compared to pentobarbital) must be required to sup-
port other processes involved in neurotransmission,
namely stabilization of the membrane potentials or post-
synaptic ion influxes (Attwell et al., 2001).
Similar to other barbiturates, inhibition of
stimulation-induced release of GABA, aspartate, gluta-
mate and/or dopamine by thiopental was demonstrated in
rat cerebrocortical slices (Minchin, 1981; Buggy et al.,
2000), cultured cerebellar neurons (Qu et al., 2000), and
synaptosomes (Pastuszko et al., 1984; Mantz et al., 1994;
Lecharny et al., 1995). In contrast to the release of neuro-
transmitters, their re-uptake is not equally modulated by
all barbiturates. Thiopental does not affect glutamate and
aspartate uptake in cerebellar neurons in culture (Qu
et al., 2000). In rat brain synaptosomes, thiopental does
not affect glutamate and GABA uptake (Sugimura et al.,
2001), although it can inhibit uptake of dopamine (Keita
et al., 1996). In a comparative study, Minchin (1981)
reported that pentobarbital could inhibit GABA and
aspartate uptake by nerve terminals, while thiopental was
devoid of effect on amino acid uptake (as well as a-
chloralose, which we employed in a past study, Sonnay
et al., 2016). In contrast to these studies, others reported
that thiopental inhibits synaptosomal uptake of aspartate,
GABA and dopamine (Pastuszko et al., 1984; Mantz
et al., 1995). To summarize, thiopental inhibits the release
of neurotransmitters and, only in certain conditions, also
their reuptake by neurons. Interestingly, thiopental was
also shown to inhibit neuronal catabolism of glutamate
(Qu et al., 2000) and GABA (Cheng and Brunner, 1981),
which may be due to the inhibition of neuronal oxidative
metabolism.
Fig. 5. Probability distribution resulting from the Monte-Carlo analysis
of the measured metabolic fluxes in the rat cortex under thiopental
(line) and a-chloralose anesthesia (shaded area).
TABLE I. Metabolic Fluxes (in mmol/g/min) in the Rat Cortex
Under Thiopental Anaesthesia Compared to Those Under
a-chloralose Anaesthesia Previously Reported in (Sonnay et al.,
2016). Fluxes were Compared with Independent Student t-tests in
a Permutation Analysis (*P< 0.05 After Correction for Multiple
Testing).
Anaesthesia
thiopental
(n5 7)
a-chloralose
(n5 8)
Measured fluxes:
Tmax 2.626 0.60 2.386 0.26
CMRglc 0.266 0.09 0.476 0.05*
VNT 0.096 0.02 0.076 0.01
VnTCA 0.466 0.02 0.536 0.02*
Vg 0.136 0.02 0.246 0.04*
VPC 0.026 0.01 0.066 0.01*
VnX 5.796 3.92
§ 1.286 0.43
V
g
X 3.456 2.84
§ 0.016 0.03
Vin 0.126 0.09 0.176 0.02
Vdil - -
Vgex 0.036 0.01 0.036 0.01
Calculated fluxes:
VGS 0.126 0.01 0.136 0.02
Vout - 0.206 0.08*
V
g
TCA 0.166 0.02 0.316 0.02*
CMRglc(ox) 0.326 0.01 0.456 0.03*
§Given the long tail of VX histograms, SD calculation for V
n
X and V
g
X in
thiopental experiments excluded values in the histogram above a thresh-
old of 20 mmol/g/min. In this case, the number of Monte-Carlo simula-
tions used was 1613 for VnX and 1160 for V
g
X.
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Interestingly, in cortical astrocytes in culture, thio-
pental inhibits glutamate uptake (Swanson and Seid,
1998). Qu et al. (1999) further reported thiopental-
induced inhibition of astrocytic glutamate metabolism
through the TCA cycle. In contrast, pentobarbital (as oth-
er oxibarbiturates) is devoid of effect on glutamate trans-
port in astrocytes cultured from either the cortex
(Swanson and Seid, 1998) or the hippocampus (Miyzaki
et al., 1997). Glutamate uptake is an energy-dependent
process. Accordingly, in the present study, only 25% of
cortical glucose oxidation, that is CMRglc(ox), occurred in
astrocytes, while it was nearly 40% under light a-
chloralose anaesthesia in either the rat cortex (Sonnay
et al., 2016) or the whole brain (Duarte et al., 2011;
Duarte and Gruetter, 2013; Lanz et al., 2014; Dehghani
et al., 2016). Furthermore, impaired clearance of synaptic
glutamate in the living brain under thiopental anaesthesia
likely results in enhanced neuronal activity and neuronal
oxidative metabolism. In fact, thiopental but not pento-
barbital was shown to produce spontaneous repetitive
action potentials in the squid giant axon, likely due to the
higher affinity of thiopental to potassium channels result-
ing in the prolongation of the falling phase of action
potentials (Sevcik, 1980). This may explain the relatively
high rate of labelling incorporation from [1,6-13C]glucose
into amino acids, namely when compared to pentobarbi-
tal experiments (Choi et al., 2002). Likewise, in the pre-
sent experiments in the living brain, VGS was similar to
that estimated under light a-chloralose anaesthesia.
Regarding the ability of thiopental to inhibit glutamine
production, there have been contrasting reports. Namely,
while Qu et al. (1999) suggested that glutamine synthesis
and release could be inhibited by thiopental in cultured
astrocytes, an earlier study found no effect (Yu et al.,
1983).
The cortical rate of glycolysis (CMRglc) was sub-
stantially lower than that estimated under a-chloralose
anaesthesia (Sonnay et al., 2016), resulting in considerably
reduced glucose consumption relative to its transport
capacity at the blood-brain-barrier (Lei et al., 2010;
Duarte and Gruetter, 2012), probably due to inhibition of
both hexokinase (Bielicki and Krieglstein, 1976) and
phosphofructokinase (Carlsson et al., 1975). Interestingly,
under thiopental anaesthesia, CMRglc(ox), i.e., the total
rate of oxidative metabolism, was estimated to be larger
than the glycolytic rate, implying a net influx of other
carbon molecules into the acetyl-CoA pool, likely from
lactate or acetate. It is noteworthy that infusion of
[1,6-13C]glucose under thiopental resulted in a nearly
two-fold increase in plasma lactate concentration relative
to what was observed in experiments under a-chloralose
anaesthesia (Duarte et al., 2011, Sonnay et al., 2016).
Hyperlactemia likely results in increased utilisation of lac-
tate by the brain owing to the facilitated diffusion mecha-
nism of MCT transporters and, therefore, [3-13C]lactate
substantially contributes to enrich carbons of cortical ami-
no acids with labelling patterns identical to those of
[1,6-13C]glucose (e.g., Gallagher et al., 2009; Boumez-
beur et al., 2010; Duarte et al., 2015). In the present
experiments with glucose infusion, rather than a net loss
of pyruvate molecules as observed under a-chloralose
anaesthesia (Duarte et al., 2011; Duarte and Gruetter,
2013; Sonnay et al., 2016), we estimated a net consump-
tion of three-carbon molecules that amounts to one fifth
of total mitochondrial metabolism. Therefore, it is likely
that lactate was used as an alternate metabolic substrate
under thiopental anaesthesia.
We proposed previously (Lanz et al., 2013) that the
exchange fluxes, VnX and V
g
X, reflecting the malate-
aspartate shuttle rate (Gruetter et al., 2001) could be asso-
ciated to the rate of mitochondrial oxidation in the
respective compartment, as this pathway is used for trans-
porting reducing equivalents into mitochondria. In this
study, there was a large uncertainty associated to the esti-
mation of the exchange fluxes VnX and V
g
X (Table I), pre-
cluding a fair comparison to results under a-chloralose
anaesthesia (Sonnay et al., 2016). Nevertheless, the mag-
nitude of these fluxes appears to be much larger than that
of the respective TCA cycle fluxes under thiopental
anaesthesia, as well as larger than under other anaesthesia
conditions (summarised in Lanz et al., 2013). According-
ly, increased aspartate-malate shuttle activity was also
observed in vivo in rats with reduced mitochondrial respi-
ration after treatment with 3-nitropropionic acid, an
inhibitor of succinate dehydrogenase (Henry et al.,
2002).
Altogether, we conclude that cortical rates of oxida-
tive metabolism in both glia and neurons are lower under
thiopental than a-chloralose anaesthesia in vivo. They
remain nevertheless substantial, as reflected by the rela-
tively high rate of labelling incorporation from
[1,6-13C]glucose into amino acids. Finally, given the low
glycolytic rate relative to neuronal and glial TCA cycle
rates, catabolism of other energy substrates is likely to be
important in the present experimental conditions.
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